News
Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine: Cambridge, Massachusetts Wednesday, July 2, 2025, 16:00 Hrs [IST] Moderna, Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback